FdaApplication
ANDA 202221
Identifiers
- fda_app_no: ANDA202221
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT III |
| application_type | ANDA |
| approval_date | 2012-06-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESCITALOPRAM OXALATE | ESCITALOPRAM OXALATE | EQ 5MG BASE/5ML | SOLUTION;ORAL |
1 product